AVCJ

TLC Capital boosts stake in Uganda-based Indian pharma JV

  • Maya Ando
  • LinkedIn  
  • Google plus  
  • Save this article  

TLG Capital has increased its stake in Quality Chemicals Industries(QCIL), the Uganda based pharmaceutical manufacturer owned by India’s leading pharmaceutical company CIPLA and Uganda-based Quality Chemicals.

No details were given as the size of the investment, but TLG - an emerging markets-focused private equity firm headquartered in London - now holds a 12.5% stake in the joint venture.

QCIL manufactures and distributes combination therapy antiretroviral (ARVs) and anti-malarial drugs (ACTs), which are said to the most effective drug treatment for HIV/AIDS and malaria. The business is supported by CIPLA, a New York-listed Indian drug manufacturer that operates globally.
 
QCIL currently produces up-to six million tablets daily, and is expected to increase production to 18 million tablets within the next 12-24 months.

Afsane Jetha, COO of TLG Capital, said in a statement “ We continually find that opportunities in the healthcare sector are some of the most compelling across the continent, and we believe that through investments such as QCIL we will be positioned at the forefront of this niche market.”

Last year, TLG Capital has invested $5 million in Kolkata-based Re-Feel Cartridges, a printer cartridge refill and laptop repair services company.

  • LinkedIn  
  • Google plus  
  • Save this article  

More on Early-stage

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs